| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |